Total Funding
77
80
Total FundingPost-IPO Equity raised
Growth Score 77 in past quarter
11 pts
Heat Score 80 in past quarter
33 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
21448
Lunai Bioworks is a biotechnology business committed to developing enhanced allogenic cell and gene therapies.
- Rene Sindlev: Co-Founder & Chairman
- Mark Dybul: CEOPast Role: The Global Fund, Executive Director
About the Company
Lunai Bioworks Inc. is a biotechnology company dedicated to the development of advanced allogenic cell and gene therapies to promote stronger immune system responses, potentially leading to long-term or life-long cancer remission in some of the deadliest cancers, as well as the treatment or cure of serious infectious diseases such as HIV and
Hepatitis B virus (HBV).
